These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8481102)

  • 1. Investigation of possible metabolism of pigment yellow 17, a 3,3'-dichlorobenzidine-based pigment, after inhalation exposure in rats.
    Hofmann T; Schmidt D
    Arch Toxicol; 1993; 67(2):141-4. PubMed ID: 8481102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1994; 68(1):8-14. PubMed ID: 8166610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of bioavailability of dichlorobenzidine form diarylide azo pigments: molecular dosimetry for hemoglobin and DNA adducts.
    Sagelsdorff P; Haenggi R; Heuberger B; Joppich-Kuhn R; Jung R; Weideli HJ; Joppich M
    Carcinogenesis; 1996 Mar; 17(3):507-14. PubMed ID: 8631137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary metabolites of 3, 3'-dichlorobenzidine and their mutagenicity (author's transl)].
    Tanaka K
    Sangyo Igaku; 1981 Jul; 23(4):426-7. PubMed ID: 7321290
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of dichlorobenzidine in the urine of rats, rabbits and monkeys treated with C.I. pigment yellow 13.
    Mondino A; Achari R; Dubini M; Marchisio MA; Silvestri S; Zanolo G
    Med Lav; 1978; 69(6):693-7. PubMed ID: 109745
    [No Abstract]   [Full Text] [Related]  

  • 6. Covalent interaction of 3,3'-dichlorobenzidine with hepatic lipids. Enzymic basis and stability of the adducts.
    Iba MM; Lang B; Thomas PE; Ghosal A
    Biochem Pharmacol; 1990 Aug; 40(3):581-7. PubMed ID: 2116801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine monitoring of textile workers exposed to dichlorobenzidine-derived pigments.
    Hatfield TR; Roberts EC; Bell IF; Clunie JC; Kalla PJ; McKay DL
    J Occup Med; 1982 Sep; 24(9):656-8. PubMed ID: 7131106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of azo colorants: influence of solubility and bioavailability.
    Golka K; Kopps S; Myslak ZW
    Toxicol Lett; 2004 Jun; 151(1):203-10. PubMed ID: 15177655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of 3,3'-dichlorobenzidine in the rat.
    Hsu RS; Sikka HC
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):306-16. PubMed ID: 7123557
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of 3,3'-dichlorobenzidine to DNA and polyribonucleotides in vitro.
    Bratcher SC; Sikka HC
    Chem Biol Interact; 1982 Feb; 38(3):369-75. PubMed ID: 7060216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinogenic and mutagenic activities of 3,3'-dichlorobenzidine derivatives--yellow transparent O and K pigments].
    Pylev LN; Vasil'eva LA; Soldatova NG; Gurski T; Galkevich E
    Gig Tr Prof Zabol; 1985 Nov; (11):34-9. PubMed ID: 4085891
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of hepatic microsomal cytochrome P-448-mediated oxidases by 3,3'-dichlorobenzidine in the rat.
    Iba MM; Sikka HC
    Biochem Pharmacol; 1983 Mar; 32(5):901-9. PubMed ID: 6838636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 3,3'-dichlorobenzidine by horseradish peroxidase.
    Lang B; Iba MM
    Xenobiotica; 1988 Aug; 18(8):893-904. PubMed ID: 3188570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroperoxidase I catalyzes peroxidative activation of 3,3'-dichlorobenzidine to a mutagen in Salmonella typhimurium.
    McGowan-Jordan IJ; Josephy PD
    Arch Biochem Biophys; 1990 Nov; 282(2):352-7. PubMed ID: 2241156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 3,3'-dichlorobenzidine: enzymic basis and toxicological consequences.
    Iba MM
    Drug Metab Rev; 1989-1990; 21(3):377-400. PubMed ID: 2701169
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.
    Ghosal A; Iba MM
    Mutat Res; 1992 Jan; 278(1):31-41. PubMed ID: 1370117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational health properties of organic pigments.
    Clin Toxicol; 1977 Sep; 11(2):277-9. PubMed ID: 891118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidative activation of 3,3'-dichlorobenzidine to mutagenic products in the Salmonella typhimurium test.
    Lang B; Iba MM
    Mutat Res; 1987; 191(3-4):139-43. PubMed ID: 3306365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary monitoring method of 3,3'-dichlorobenzidine (DCB) and its metabolites, N-acetyl-DCB and N,N'-diacetyl-DCB.
    Lee JH; Shin HS; Jung DG; Lee YS
    Ind Health; 2003 Jul; 41(3):242-8. PubMed ID: 12916755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.